Medical economics and the assessment of value in cardiovascular medicine: Part I.
Publication
, Journal Article
Mark, DB; Hlatky, MA
Published in: Circulation
July 23, 2002
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 23, 2002
Volume
106
Issue
4
Start / End Page
516 / 520
Location
United States
Related Subject Headings
- Terminology as Topic
- Randomized Controlled Trials as Topic
- Humans
- Health Care Costs
- Forecasting
- Cost-Benefit Analysis
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- 4207 Sports science and exercise
Citation
APA
Chicago
ICMJE
MLA
NLM
Mark, D. B., & Hlatky, M. A. (2002). Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation, 106(4), 516–520. https://doi.org/10.1161/01.cir.0000021407.93752.7b
Mark, Daniel B., and Mark A. Hlatky. “Medical economics and the assessment of value in cardiovascular medicine: Part I.” Circulation 106, no. 4 (July 23, 2002): 516–20. https://doi.org/10.1161/01.cir.0000021407.93752.7b.
Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation. 2002 Jul 23;106(4):516–20.
Mark, Daniel B., and Mark A. Hlatky. “Medical economics and the assessment of value in cardiovascular medicine: Part I.” Circulation, vol. 106, no. 4, July 2002, pp. 516–20. Pubmed, doi:10.1161/01.cir.0000021407.93752.7b.
Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation. 2002 Jul 23;106(4):516–520.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 23, 2002
Volume
106
Issue
4
Start / End Page
516 / 520
Location
United States
Related Subject Headings
- Terminology as Topic
- Randomized Controlled Trials as Topic
- Humans
- Health Care Costs
- Forecasting
- Cost-Benefit Analysis
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- 4207 Sports science and exercise